Protheragen Inc. logo

Protheragen Inc.

Protheragen Inc. ("Protheragen") focuses on acquiring, developing and commercializing novel pharmaceutical and biotechnology products for both therapeutic purposes and diagnostic applications. Guided by our advanced business strategy – the “VIC R&D model”: V (risk investment), I (IP right) and C (CRO), we are dedicated to making drug discovery and development activities the most effective via a collection of efforts and advantages from all agencies. Our streamlined management structure and rich trading experience allow us to seize opportunities that may elapse in a second and enable us to select from a series of options the best corporate or financial structure so as to successfully develop each product candidate.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.protheragen.com
Founded
Disease Focus
Development Stage
STOCK CODENon Listed
Address
2200 Smithtown Avenue, Room 1, NY 11779-7329
Ronkonkoma
United States
Email
Contact Number
+1-516-765-9461

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/protheragen-inc-” connections=”true” suffix=””]